8-K: Privia Health Reports Strong 2024 Results, Exceeding Guidance and Forecasting Continued Growth in 2025

Privia Health announced its fourth quarter and full-year 2024 financial results, exceeding guidance across all operating and financial metrics and projecting continued momentum into 2025 despite industry headwinds.

Summary

• Privia Health reported its fourth quarter and full-year 2024 financial results on February 27, 2025.
• The company's performance exceeded the high end of its guidance ranges for 2024.
• Total revenue for 2024 was $1,736.4 million, a 4.7% increase from 2023.
• Gross profit increased by 12.4% to $397.7 million.
• Net income was $14.4 million, which is down 37.7% from the previous year, but non-GAAP adjusted net income increased by 19.8% to $97.6 million.
• Adjusted EBITDA grew by 25.2% to $90.5 million.
• Net cash provided by operating activities was $109.3 million, a 35.3% increase from 2023.
• The company ended 2024 with a cash balance of $491.1 million and no debt.
• Privia Health is guiding for continued growth in 2025, with revenue projected to be between $1.8 billion and $1.9 billion.
• The company expects to convert at least 80% of Adjusted EBITDA to Free Cash Flow in full-year 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results exceeding guidance, significant growth in key metrics, and a healthy cash position. While there are some challenges noted in the Medicare Advantage environment, the overall tone is optimistic and suggests continued success for Privia Health.

Positives

• The company's operating and financial performance metrics were above the high end of its guidance ranges for 2024.
• Implemented Providers increased +11.2% from 2023.
• Fee-for-service collections growth of +13.6% year over year.
• Shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a +34.1% increase from 2022.
• Adjusted EBITDA growth of +25.2% over full-year 2023.
• Full-year 2024 Net Cash Provided by Operating Activities was $109.3 million compared to $80.8 million in 2023 (+35.3%) with de minimis capital expenditures.
• Free cash flow of $109.3 million (+35.4% year over year), approximately 121% of Adjusted EBITDA.
• The company ended 2024 with a cash balance of $491.1 million and no debt.

Negatives

• Net income for full-year 2024 decreased by 37.7% compared to 2023, primarily due to increased non-cash stock compensation expense and legal, non-recurring, and other expenses.
• The company anticipates minimal year-over-year increase in value-based shared savings accruals given current environment.

Risks

• The company faces challenges in the Medicare Advantage and value-based environment.
• The company's guidance assumes no new business development activity or capital deployment.
• The company's effective tax rate is expected to be approximately 26-28%.

Future Outlook

Privia Health anticipates continued growth in 2025, with revenue projected to be between $1.8 billion and $1.9 billion and Adjusted EBITDA between $105 million and $110 million. The company expects to convert at least 80% of Adjusted EBITDA to Free Cash Flow in full-year 2025.

Management Comments

• Privia Health's key actions and areas of focus in 2025 include increasing density and scale in existing states through organic provider growth.
• Privia Health's key actions and areas of focus in 2025 include continuing to perform in value-based risk arrangements for positive margin contribution in challenging Medicare Advantage (MA) market.
• Privia Health's key actions and areas of focus in 2025 include achieving operating leverage to drive Adjusted EBITDA growth, and converting at least 80% of Adjusted EBITDA to Free Cash Flow.
• Privia Health's key actions and areas of focus in 2025 include pursuing business development efforts to enter new states and expand in existing states to increase overall addressable market.

Industry Context

Privia Health operates in the physician enablement and value-based care sector, which is experiencing growth due to the increasing focus on healthcare cost reduction and improved patient outcomes. The company's performance is notable given the challenging Medicare Advantage environment, suggesting a strong competitive position.

Comparison to Industry Standards

• Privia Health's growth in attributed lives and implemented providers is competitive with other physician enablement companies like Agilon Health and Oak Street Health.
• The company's focus on converting Adjusted EBITDA to free cash flow aligns with industry best practices for financial efficiency.
• The company's shared savings performance in the MSSP program is a key indicator of its success in value-based care, which is a growing trend in the healthcare industry.

Stakeholder Impact

• Shareholders can expect continued growth and profitability, as indicated by the company's guidance.
• Employees can anticipate a stable and growing work environment.
• Customers (patients) should benefit from improved care coordination and outcomes through Privia Health's platform.
• Suppliers and creditors can expect timely payments and continued business relationships.

Next Steps

• The company will host a conference call on February 27, 2025, to discuss these results and management's outlook.
• The company will continue to focus on increasing density and scale in existing states through organic provider growth.
• The company will continue to perform in value-based risk arrangements for positive margin contribution in challenging Medicare Advantage (MA) market.
• The company will continue to achieve operating leverage to drive Adjusted EBITDA growth, and converting at least 80% of Adjusted EBITDA to Free Cash Flow.
• The company will continue to pursue business development efforts to enter new states and expand in existing states to increase overall addressable market.

Key Dates